Continuous vs stent‐removal antibiotic prophylaxis after cystectomy: a retrospective analysis

OBJECTIVES: To compare the efficacy and microbiological consequences of continuous prophylaxis (CP) vs stent-removal prophylaxis (SRP) in patients undergoing cystectomy with urinary diversion. PATIENTS AND METHODS: This single-centre retrospective cohort study included 223 patients undergoing cystectomy with urinary diversion from 2015 to 2024. All patients received identical perioperative intravenous prophylaxis (cefazolin and metronidazole for up to 48 h). Groups were defined by the subsequent oral strategy: SRP (n = 119), a 3-day course of amoxicillin-clavulanate around stent removal, vs CP (n = 104), amoxicillin-clavulanate given continuously from completion of intravenous prophylaxis until the day after stent removal. Primary endpoints included surgical site infection (SSI), urinary tract infection (UTI), readmission rates, and new isolation of organisms not covered by the prophylactic regimen. Multivariable logistic and negative binomial regression models adjusted for pre-specified confounders. RESULTS: The CP group had a higher median Charlson Comorbidity Index (4 vs 3, P = 0.023). Despite a median antibiotic duration of 16.0 (CP) vs 7.0 days (SRP) (P < 0.001), no significant differences were observed in UTI (27.9% vs 31.9%, P = 0.6), SSI (28.8% vs 28.6%, P > 0.9), or 30-day readmission (26.0% vs 29.4%, P = 0.7). CP was associated with significantly higher isolation of new organisms not covered by the prophylactic regimen (32.7% vs 19.3%, P = 0.031) and new Pseudomonas aeruginosa isolation (15.4% vs 2.5%, P < 0.001). CP was associated with postoperative Pseudomonas isolation after adjustment using Firth's penalised logistic regression (odds ratio 5.50, 95% confidence interval 1.77-22.36, P = 0.002). CONCLUSION: Continuous prophylaxis was not associated with fewer infectious complications or readmissions but was associated with increased isolation of organisms not covered by prophylaxis, particularly P. aeruginosa. Given the non-randomised historical before-after design, non-overlapping study periods, and baseline differences, these findings remain hypothesis-generating.

Authors

Institutions

Publication Details

Journal
British Journal of Urology
Published
2026-11-16
DOI
https://doi.org/10.1111/bju.70544
Primary Topic
Surgical site infection prevention
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Continuous vs stent‐removal antibiotic prophylaxis after cystectomy: a retrospective analysis

Matthew D. M. Rawlins, Dickon Hayne, Katie L. Meehan, Edward Raby et al.
2 links
British Journal of Urology
Surgical site infection prevention
article

Continuous vs stent‐removal antibiotic prophylaxis after cystectomy: a retrospective analysis

Matthew D. M. Rawlins, Dickon Hayne, Katie L. Meehan, Edward Raby, K.G. Keane, Sam McDonald, Ruth Tiong, Alexandra Votrubec
article en

Abstract

OBJECTIVES: To compare the efficacy and microbiological consequences of continuous prophylaxis (CP) vs stent-removal prophylaxis (SRP) in patients undergoing cystectomy with urinary diversion. PATIENTS AND METHODS: This single-centre retrospective cohort study included 223 patients undergoing cystectomy with urinary diversion from 2015 to 2024. All patients received identical perioperative intravenous prophylaxis (cefazolin and metronidazole for up to 48 h). Groups were defined by the subsequent oral strategy: SRP (n = 119), a 3-day course of amoxicillin-clavulanate around stent removal, vs CP (n = 104), amoxicillin-clavulanate given continuously from completion of intravenous prophylaxis until the day after stent removal. Primary endpoints included surgical site infection (SSI), urinary tract infection (UTI), readmission rates, and new isolation of organisms not covered by the prophylactic regimen. Multivariable logistic and negative binomial regression models adjusted for pre-specified confounders. RESULTS: The CP group had a higher median Charlson Comorbidity Index (4 vs 3, P = 0.023). Despite a median antibiotic duration of 16.0 (CP) vs 7.0 days (SRP) (P < 0.001), no significant differences were observed in UTI (27.9% vs 31.9%, P = 0.6), SSI (28.8% vs 28.6%, P > 0.9), or 30-day readmission (26.0% vs 29.4%, P = 0.7). CP was associated with significantly higher isolation of new organisms not covered by the prophylactic regimen (32.7% vs 19.3%, P = 0.031) and new Pseudomonas aeruginosa isolation (15.4% vs 2.5%, P < 0.001). CP was associated with postoperative Pseudomonas isolation after adjustment using Firth's penalised logistic regression (odds ratio 5.50, 95% confidence interval 1.77-22.36, P = 0.002). CONCLUSION: Continuous prophylaxis was not associated with fewer infectious complications or readmissions but was associated with increased isolation of organisms not covered by prophylaxis, particularly P. aeruginosa. Given the non-randomised historical before-after design, non-overlapping study periods, and baseline differences, these findings remain hypothesis-generating.

British Journal of Urology
The University of Western Australia (AU), Harry Perkins Institute of Medical Research (AU), Fiona Stanley Hospital (AU), Australian and New Zealand Urogenital and Prostate Cancer Trials Group (AU)
Good health and well-being
Surgical site infection prevention
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon